Bendell, Johanna C.; Montagut Viladot, Clara; Hurwitz, Herbert; McCAVE Study Group
(Wiley, 2020)
Background: Bevacizumab, a VEGF-A inhibitor, in combination with chemotherapy, has proven to increase progression-free survival (PFS) and overall survival in multiple lines of therapy of metastatic colorectal cancer (mCRC). ...